glp-1 drugs pharmaceutical companies news 2025 trends 2025: real-world data, patient outcomes & future therapies Patients Face New Barriers for

Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths

Neuropharmacology 123 , 6779, (2017)

Authors contributions Drafting the manuscript, creating figures and tables (WMW), and critically revising the document for important intellectual content (LGL)

Looking ahead, as the GLP-1 class of drugs continues to improve and side effects decrease, there is a potential future where many people incorporate a GLP-1 derivative into their daily routine

It is also worth noting that GLP-1RAs are not without complexity in the chronic illness world, especially for patients with EDS or significant gastrointestinal dysmotility